Pregnancy in a patient with adrenal carcinoma treated with mitotane: A case report and review of literature

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 2, 2013, Pages 443-447

  Tripto Shkolnik, Liana ^a   Blumenfeld, Zeev ^b   Bronshtein, Moshe ^c   Salmon, Asher ^d   Jaffe, Anat ^a  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; GLUCOCORTICOID; KETOCONAZOLE; MINERALOCORTICOID; MITOTANE; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE;

ADRENAL CORTEX CARCINOMA; ADULT; ANKLE EDEMA; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; FEMALE; FETUS ECHOGRAPHY; FOLLOW UP; GESTATIONAL AGE; HIRSUTISM; HUMAN; HYPERCORTISOLISM; HYPOKALEMIA; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREGNANCY TERMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SKIN BRUISING; TREATMENT DURATION;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; FATAL OUTCOME; FEMALE; HUMANS; MITOTANE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 84873641073     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2839     Document Type: Review

References (18)

1. Fassnacht M, Terzolo M, Allolio B, et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med. 2012; 366:2189-2197.
2. Jeruss JS, Woodruff TK. Preservation of fertility in patients with cancer. N Engl J Med. 2009;360:902-911.
3. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update. 2008;14:543-552.
4. Allolio B, Fassnacht M. Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab. 2006;91:2027-2037.
5. Fassnacht M, Libe R, Kroiss M, Allolio B. Adrenocortical carcinoma: a clinician's update. Nat Rev Endocrinol. 2011;7:323-335.
6. De Francia S, Ardito A, Daffara F, et al. Mitotane treatment for adrenocortical carcinoma: an overview. Minerva Endocrinol. 2012; 37:9-23.
7. Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. NEngl J Med. 2007;356:2372-2380.
8. Abiven-Lepage G, Coste J, Tissier F, et al. Adrenocortical carcinoma and pregnancy: clinical and biological features and prognosis. Eur J Endocrinol. 2010;163:793-800.
9. Kotteas E, Ioachim E, Pavlidis N. A pregnant patient with adrenocortical carcinoma: case report. Onkologie. 2012;35:517-519.
10. Homer L, Viatge M, Gayet FX, Laurent Y, Kerlan V. [Cushing syndrome and pregnancy: a propos of a malignant adrenocortical carcinoma]. Gynecol Obstet Fertil. 2012;40:e1-e4.
11. Foster W, Chan S, Platt L, Hughes C. Detection of endocrine disrupting chemicals in samples of second trimester human amniotic fluid. J Clin Endocrinol Metab. 2000;85:2954-2957.
12. Luton JP, Remy JM, Valcke JC, Laudat P, Bricaire H. [Recovery or remission of Cushing's disease following long term administration of op'DDD in seventeen patients (author's translation)]. Ann Endocrinol (Paris). 1973;34:351-376.
13. Leiba S, Kaufman H, Winkelsberg G, Bahary CM. Pregnancy in a case of Nelson's syndrome. Acta Obstet Gynecol Scand. 1978;57: 373-375.
14. Leiba S, Weinstein R, Shindel B, et al. The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo. Ann Endocrinol (Paris). 1989;50:49-53.
15. Gerl H, Benecke R, Knappe G, Rohde W, Stahl F, Amendt P. Pregnancy and partus in Cushing's disease treated with o,p'-DDD. Acta Endocrinol (Copenh). 1992;126:133.
16. Baszko-Błaszyk D, Ochmań ska K, Waśko R, Sowiń ski J. Pregnancy in a patient with adrenocortical carcinoma during treatment with mitotane-a case report. Endokrynol Pol. 2011;62:186-188.
17. Kojori F, Cronin CM, Salamon E, Burym C, Sellers EA. Normal adrenal function in an infant following a pregnancy complicated by maternal adrenal cortical carcinoma and mitotane exposure. J Pediatr Endocrinol Metab. 2011;24:203-204.
18. Bronshtein M, Tzidony D, Dimant M, Hajos J, Jaeger M, Blumenfeld Z. Transvaginal ultrasonographic measurements of the fetal adrenal glands at 12 to 17 weeks of gestation. AmJ Obstet Gynecol. 1993;169:1205-1210.